Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Phase I trial of an ICAM-1-targeted immunotherapeutic-coxsackievirus A21 (CVA21) as an oncolytic agent against non muscle-invasive bladder cancer
Progress looks different for everyone
The company announced that it has fully eliminated FD&C colours from products sold across its US food and beverage business, fulfilling a commitment made in 2025 to accelerate the transition away from synthetic colour additives
Frequently asked questions What exactly is PTD-DBM and how does it work
Navic je komplex kov-peptid citlivy a po dermalni injekci je popisovana rychla clearance
US$ 23.93
US$ 25.50
US$ 22.29
US$ 26.01
US$ 23.20
US$ 21.38
